A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy

A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy

Mutations in the lysosomal enzyme glucocerebrosidase (GCase, GBA1 gene) are the most common genetic risk factor for developing Parkinson's disease (PD). GCase metabolizes the glycosphingolipids glucosylceramide (GlcCer) and glucosylsphingosine (GlcSph). Mutations in GBA1 reduce enzyme activity...

Full description

Bibliographic Details
Main Authors:	Mali Cosden, Sarah Jinn, Lihang Yao, Cheryl A. Gretzula, Monika Kandebo, Dawn Toolan, Nathan G. Hatcher, Lei Ma, Wei Lemaire, Gregory C. Adam, Christine Burlein, Christina Minnick, Rose Flick, Marla L. Watt, James Mulhearn, Mark Fraley, Robert E. Drolet, Jacob N. Marcus, Sean M. Smith
Format:	Article
Language:	English
Published:	Elsevier 2021-11-01
Series:	Neurobiology of Disease
Subjects:	Glucocerebrosidase Glucosylceramide synthase inhibitor Glycosphingolipids Parkinson's disease Lysosomal biology Preformed fibril model
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996121002564

Similar Items

Glucosylceramide Synthase Is Involved in Development of Invariant Natural Killer T Cells
by: Zoran V. Popovic, et al.
Published: (2017-07-01)

Glucosylceramide flippases contribute to cellular glucosylceramide homeostasis
by: Natsuki Kita, et al.
Published: (2024-03-01)

Glucosylceramide synthase regulates hepatocyte repair after concanavalin A-induced immune-mediated liver injury
by: Jian Gan, et al.
Published: (2021-09-01)

Selective Targeting of the Interconversion between Glucosylceramide and Ceramide by Scaffold Tailoring of Iminosugar Inhibitors
by: Cécile Baudoin-Dehoux, et al.
Published: (2019-01-01)

A new glucocerebrosidase-deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease
by: Wendy Westbroek, et al.
Published: (2016-07-01)

Glycosphingolipids and Infection. Potential New Therapeutic Avenues
by: Johannes M. F. G. Aerts, et al.
Published: (2019-12-01)

Genetic Characterization of the Acidic and Neutral Glycosphingolipid Biosynthetic Pathways in <i>Neurospora crassa</i>
by: Jannatul F. Shoma, et al.
Published: (2023-08-01)

Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
by: Mylene Huebecker, et al.
Published: (2019-11-01)

Glycosphingolipid levels in an unusual neurovisceral storage disease characterized by lactosylceramide galactosyl hydrolase deficiency: lactosylceramidosis
by: Glyn Dawson
Published: (1972-03-01)

Structure and biological functions of fungal cerebrosides
by: Barreto-Bergter Eliana, et al.
Published: (2004-01-01)

Structural diversity and biological significance of glycosphingolipids in pathogenic and opportunistic fungi
by: Luciana Lopes Guimaraes, et al.
Published: (2014-09-01)

Ambroxol Hydrochloride Improves Motor Functions and Extends Survival in a Mouse Model of Familial Amyotrophic Lateral Sclerosis
by: Alexandra Bouscary, et al.
Published: (2019-08-01)

Horse-Derived Ceramide Accentuates Glucosylceramide Synthase and Ceramide Synthase 3 by Activating PPARβ/δ and/or PPARγ to Stimulate Ceramide Synthesis
by: Tami Igarashi, et al.
Published: (2023-02-01)

The Enigmatic Role of GBA2 in Controlling Locomotor Function
by: Marina A. Woeste, et al.
Published: (2017-11-01)

Identification of GM1-Ganglioside Secondary Accumulation in Fibroblasts from Neuropathic Gaucher Patients and Effect of a Trivalent Trihydroxypiperidine Iminosugar Compound on Its Storage Reduction
by: Costanza Ceni, et al.
Published: (2024-01-01)

Enhanced calcium release in the acute neuronopathic form of Gaucher disease
by: Dori Pelled, et al.
Published: (2005-02-01)

β-Glucocerebrosidase activity in mammalian stratum corneum
by: Yutaka Takagi, et al.
Published: (1999-05-01)

Glycosphingolipids in Filamentous Fungi: Biological Roles and Potential Applications in Cosmetics and Health Foods
by: Chunmiao Jiang, et al.
Published: (2021-07-01)

ATP-binding cassette transporters mediate differential biosynthesis of glycosphingolipid species
by: Monique Budani, et al.
Published: (2021-01-01)

Differential Regulation of Glucosylceramide Synthesis and Efflux by Golgi and Plasma Membrane Bound ABCC10
by: Jahangir Iqbal, et al.
Published: (2023-01-01)

Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations
by: Andrew E. Arrant, et al.
Published: (2019-12-01)

Defining the glucosylceramide population of C. elegans
by: Mark A. Xatse, et al.
Published: (2023-09-01)

Blockade of Glycosphingolipid Synthesis Inhibits Cell Cycle and Spheroid Growth of Colon Cancer Cells In Vitro and Experimental Colon Cancer Incidence In Vivo
by: Richard Jennemann, et al.
Published: (2021-09-01)

Assay for the transbilayer distribution of glycolipids: selective oxidation of glucosylceramide to glucuronylceramide by TEMPO nitroxyl radicals
by: Daniel J. Sillence, et al.
Published: (2000-08-01)

Property-based design of a glucosylceramide synthase inhibitor that reduces glucosylceramide in the brain
by: Scott D. Larsen, et al.
Published: (2012-02-01)

Glucosylated cholesterol in mammalian cells and tissues: formation and degradation by multiple cellular β-glucosidases[S]
by: AndréR.A. Marques, et al.
Published: (2016-03-01)

Glucocerebrosidase involvement in Parkinson Disease and other Synucleinopathies
by: Maria Rosario Almeida
Published: (2012-04-01)

CgGCS, Encoding a Glucosylceramide Synthase, Is Required for Growth, Conidiation and Pathogenicity in Colletotrichum gloeosporioides
by: Yimei Huang, et al.
Published: (2019-05-01)

PS Dependent APP Cleavage Regulates Glucosylceramide Synthase and is Affected in Alzheimer's Disease
by: Marcus O.W. Grimm, et al.
Published: (2014-06-01)

Quantification of glucosylceramide in plasma of Gaucher disease patients
by: Maria Viviane Gomes Muller, et al.
Published: (2010-12-01)

Glucosylceramide Plays a Role in Fungal Germination, Lipid Raft Organization and Biofilm Adhesion of the Pathogenic Fungus <i>Scedosporium aurantiacum</i>
by: Victor Pereira Rochetti, et al.
Published: (2020-12-01)

Glucosylceramide modulates membrane traffic along the endocytic pathway
by: Dan J. Sillence, et al.
Published: (2002-11-01)

Are Glucosylceramide-Related Sphingolipids Involved in the Increased Risk for Cancer in Gaucher Disease Patients? Review and Hypotheses
by: Patricia Dubot, et al.
Published: (2020-02-01)

Structural Differences Influence Biological Properties of Glucosylceramides from Clinical and Environmental Isolates of <i>Scedosporium aurantiacum</i> and <i>Pseudallescheria minutispora</i>
by: Adriana Caneppa, et al.
Published: (2019-07-01)

Comparative Study on Epidermal Moisturizing Effects and Hydration Mechanisms of Rice-Derived Glucosylceramides and Ceramides
by: Shogo Takeda, et al.
Published: (2022-12-01)

Glucosylceramides From Lomentospora prolificans Induce a Differential Production of Cytokines and Increases the Microbicidal Activity of Macrophages
by: Mariana Ingrid Dutra da Silva Xisto, et al.
Published: (2019-03-01)

Glucosylceramide Changes Bacterial Metabolism and Increases Gram-Positive Bacteria through Tolerance to Secondary Bile Acids In Vitro
by: Huanghuang Dai, et al.
Published: (2022-05-01)

Fungal Glucosylceramide-Specific Camelid Single Domain Antibodies Are Characterized by Broad Spectrum Antifungal Activity
by: Barbara De Coninck, et al.
Published: (2017-06-01)

Glucosylceramides from <i>Cladosporium</i> and Their Roles in Fungi–Plant Interaction
by: Mariana Ingrid Dutra da Silva Xisto, et al.
Published: (2022-06-01)

Convenient and Sensitive Measurement of Lactosylceramide Synthase Activity Using Deuterated Glucosylceramide and Mass Spectrometry
by: Michele Dei Cas, et al.
Published: (2023-03-01)